Bausch + Lomb Seeks $840 Million in IPO That Could Ease Drought

Bausch + Lomb Corp., the contact lens maker, has filed to raise as much as $840 million in an initial public offering, a long-awaited deal that may show green shoots in U.S. capital markets.

The company being spun out of Bausch Health Cos. plans to sell 35 million shares for $21 to $24 apiece, according to a filing Thursday with the U.S. Securities and Exchange Commission. All of the proceeds from the IPO will go to Bausch Health as the selling shareholder, the filing shows.

At the top of the price range, Bausch + Lomb would have a market ...